Cibus, Inc. (CBUS)
USD 2.25
(5.14%)
USD 2.25
(5.14%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -267.62 Million USD | -1484.44% |
| 2022 | -16.89 Million USD | 42.15% |
| 2021 | -29.19 Million USD | 34.88% |
| 2020 | -44.83 Million USD | -13.19% |
| 2019 | -39.61 Million USD | -41.99% |
| 2018 | -27.89 Million USD | -7.38% |
| 2017 | -25.98 Million USD | -114.96% |
| 2016 | -12.08 Million USD | -105.23% |
| 2015 | -5.88 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -24.88 Million USD | -6.18% |
| 2024 Q1 | -23.43 Million USD | 88.69% |
| 2023 Q3 | -34.52 Million USD | -68.36% |
| 2023 Q4 | -207.19 Million USD | -500.08% |
| 2023 Q1 | -5.39 Million USD | -90.13% |
| 2023 Q2 | -20.5 Million USD | -280.22% |
| 2023 FY | -267.62 Million USD | -1484.44% |
| 2022 Q1 | -5.61 Million USD | 20.38% |
| 2022 FY | -16.89 Million USD | 42.15% |
| 2022 Q4 | -2.83 Million USD | 52.32% |
| 2022 Q3 | -5.95 Million USD | -139.44% |
| 2022 Q2 | -2.48 Million USD | 55.78% |
| 2021 Q2 | -4.8 Million USD | 52.06% |
| 2021 Q4 | -7.05 Million USD | 3.42% |
| 2021 Q1 | -10.02 Million USD | 25.14% |
| 2021 Q3 | -7.3 Million USD | -52.01% |
| 2021 FY | -29.19 Million USD | 34.88% |
| 2020 Q2 | -10.9 Million USD | 1.46% |
| 2020 FY | -44.83 Million USD | -13.19% |
| 2020 Q4 | -13.39 Million USD | -41.36% |
| 2020 Q3 | -9.47 Million USD | 13.08% |
| 2020 Q1 | -11.06 Million USD | 9.06% |
| 2019 Q4 | -12.16 Million USD | -14.02% |
| 2019 Q3 | -10.66 Million USD | -13.46% |
| 2019 Q2 | -9.4 Million USD | -27.5% |
| 2019 FY | -39.61 Million USD | -41.99% |
| 2019 Q1 | -7.37 Million USD | 12.91% |
| 2018 Q2 | -7.57 Million USD | -73.36% |
| 2018 Q1 | -4.37 Million USD | 36.2% |
| 2018 Q4 | -8.46 Million USD | -13.16% |
| 2018 FY | -27.89 Million USD | -7.38% |
| 2018 Q3 | -7.48 Million USD | 1.23% |
| 2017 Q4 | -6.84 Million USD | 46.92% |
| 2017 FY | -25.98 Million USD | -114.96% |
| 2017 Q3 | -12.9 Million USD | -280.09% |
| 2017 Q1 | -2.83 Million USD | 37.8% |
| 2017 Q2 | -3.39 Million USD | -19.88% |
| 2016 Q2 | -2.45 Million USD | 4.36% |
| 2016 Q1 | -2.56 Million USD | 0.0% |
| 2016 FY | -12.08 Million USD | -105.23% |
| 2016 Q4 | -4.55 Million USD | -81.61% |
| 2016 Q3 | -2.5 Million USD | -2.04% |
| 2015 FY | -5.88 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -2547.937% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -423.127% |
| XOMA Corporation | -40.83 Million USD | -555.451% |
| Mesoblast Limited | -87.95 Million USD | -204.274% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -329.888% |
| Aptorum Group Limited | -2.82 Million USD | -9374.706% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -1894.654% |
| HilleVax, Inc. | -123.56 Million USD | -116.586% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -8.971% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -500.016% |
| Precision BioSciences, Inc. | -61.31 Million USD | -336.45% |
| Dyadic International, Inc. | -6.79 Million USD | -3838.32% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -2439.638% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -136.92% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -28492.628% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -840.626% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -278.031% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -18.813% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -115.682% |
| IGM Biosciences, Inc. | -246.41 Million USD | -8.608% |
| Opthea Limited | -220.24 Million USD | -21.515% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -348.399% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -393.886% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -129.412% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 613.148% |
| NextCure, Inc. | -62.72 Million USD | -326.681% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -1306.425% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -411.334% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -893.492% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -800.343% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -62.618% |
| Senti Biosciences, Inc. | -92.91 Million USD | -188.022% |
| Apollomics, Inc. | -172.6 Million USD | -55.055% |
| PureTech Health plc | -65.69 Million USD | -307.366% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -577.897% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -264.878% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -82.106% |
| ChromaDex Corporation | -4.93 Million USD | -5319.745% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -3085.203% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -415.411% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -3.799% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -3333.453% |
| Gritstone bio, Inc. | -138.49 Million USD | -93.246% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -1661.92% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -66.302% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -49.468% |
| Fortress Biotech, Inc. | -60.63 Million USD | -341.359% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -416.186% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -789.304% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -14.062% |
| Celcuity Inc. | -63.77 Million USD | -319.615% |
| ContextLogic Inc. | -317 Million USD | 15.575% |
| GH Research PLC | -35.58 Million USD | -652.036% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -228.055% |
| Cassava Sciences, Inc. | -97.21 Million USD | -175.288% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -1086.553% |
| ImmuCell Corporation | -5.77 Million USD | -4534.556% |
| Amarin Corporation plc | -59.11 Million USD | -352.746% |
| TG Therapeutics, Inc. | 12.67 Million USD | 2211.955% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -164.54% |
| Acelyrin, Inc. | -381.64 Million USD | 29.875% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -5485.493% |
| Seer, Inc. | -86.27 Million USD | -210.195% |
| Novavax, Inc. | -545.06 Million USD | 50.9% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -32.757% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 164.515% |
| AnaptysBio, Inc. | -163.61 Million USD | -63.567% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -1437.114% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -288.09% |
| AbCellera Biologics Inc. | -146.39 Million USD | -82.808% |
| CorMedix Inc. | -46.33 Million USD | -477.539% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -21.809% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -1805.375% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 106.769% |
| Aptose Biosciences Inc. | -51.2 Million USD | -422.638% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -172.261% |
| Soligenix, Inc. | -6.14 Million USD | -4258.228% |
| Century Therapeutics, Inc. | -136.67 Million USD | -95.816% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -30.375% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1343.037% |
| Kura Oncology, Inc. | -152.63 Million USD | -75.342% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -129.137% |
| Ardelyx, Inc. | -66.06 Million USD | -305.084% |
| Ainos, Inc. | -13.77 Million USD | -1843.474% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -199.97% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 47428.24% |
| Prothena Corporation plc | -147.02 Million USD | -82.025% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -46934.622% |
| Autolus Therapeutics plc | -208.38 Million USD | -28.43% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -272.231% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -135.026% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -1135.126% |
| Celularity Inc. | -196.29 Million USD | -36.339% |
| Rallybio Corporation | -74.56 Million USD | -258.923% |
| GRI Bio, Inc. | -13.03 Million USD | -1952.827% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -6372.898% |
| Omeros Corporation | -117.81 Million USD | -127.163% |
| INmune Bio, Inc. | -30 Million USD | -791.852% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -142.067% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -534.281% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1576.687% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -1594.38% |
| Humacyte, Inc. | -110.77 Million USD | -141.593% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 3.078% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -12.499% |
| Immunocore Holdings plc | -55.28 Million USD | -384.069% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1388.139% |
| Verastem, Inc. | -87.36 Million USD | -206.325% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -65.882% |
| Histogen Inc. | -10.62 Million USD | -2419.791% |
| Surrozen, Inc. | -43.04 Million USD | -521.781% |
| Blueprint Medicines Corporation | -506.98 Million USD | 47.212% |
| Organovo Holdings, Inc. | -14.67 Million USD | -1724.191% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -5160.969% |
| IO Biotech, Inc. | -86.08 Million USD | -210.894% |
| MEI Pharma, Inc. | 17.77 Million USD | 1605.383% |
| GT Biopharma, Inc. | -7.59 Million USD | -3422.798% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -77.137% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -447.003% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -295.459% |
| Summit Therapeutics Inc. | -614.92 Million USD | 56.478% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -661.602% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -89.263% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -2468.963% |
| Turnstone Biologics Corp. | -55.2 Million USD | -384.832% |
| Pulmatrix, Inc. | -14.12 Million USD | -1795.241% |
| Synaptogenix, Inc. | -6.03 Million USD | -4332.008% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -1551.203% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -243.024% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -223.855% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 44.382% |
| Cytokinetics, Incorporated | -526.24 Million USD | 49.144% |
| Exelixis, Inc. | 207.76 Million USD | 228.812% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -85.919% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 49.373% |
| Evogene Ltd. | -23.87 Million USD | -1020.763% |
| Replimune Group, Inc. | -215.79 Million USD | -24.02% |
| PDS Biotechnology Corporation | -42.94 Million USD | -523.226% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -3311.264% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -315.151% |
| ESSA Pharma Inc. | -26.58 Million USD | -906.785% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -6590.759% |
| BioLineRx Ltd. | -60.61 Million USD | -341.527% |
| Avid Bioservices, Inc. | -140.75 Million USD | -90.139% |
| Insmed Incorporated | -749.56 Million USD | 64.296% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -811.474% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 8.407% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -860.062% |
| MediWound Ltd. | -6.71 Million USD | -3884.917% |
| MiMedx Group, Inc. | 67.43 Million USD | 496.843% |
| OmniAb, Inc. | -50.61 Million USD | -428.709% |
| Alector, Inc. | -130.39 Million USD | -105.25% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -135.33% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 57.289% |
| Mereo BioPharma Group plc | -29.46 Million USD | -808.257% |
| Zai Lab Limited | -334.62 Million USD | 20.021% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 17.396% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -27.831% |
| Aura Biosciences, Inc. | -76.4 Million USD | -250.26% |
| Immunic, Inc. | -93.61 Million USD | -185.89% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -13.432% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -96.94% |
| Veracyte, Inc. | -74.4 Million USD | -259.694% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -3386.747% |
| FibroGen, Inc. | -284.23 Million USD | 5.842% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -920.231% |
| Allakos Inc. | -185.7 Million USD | -44.117% |
| scPharmaceuticals Inc. | -54.81 Million USD | -388.281% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -174.955% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 352.145% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -3722.211% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2098.705% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -1321.077% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 643.173% |
| Precigen, Inc. | -95.9 Million USD | -179.057% |
| Fortrea Holdings Inc. | -3.4 Million USD | -7771.382% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -111.322% |
| Incyte Corporation | 597.59 Million USD | 144.784% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -2590.328% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -125.821% |
| XBiotech Inc. | -24.55 Million USD | -989.82% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -205.235% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -315.151% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -999.568% |
| CRISPR Therapeutics AG | -153.61 Million USD | -74.225% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -76.35% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -662.058% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -326.974% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -171.907% |
| Agenus Inc. | -245.76 Million USD | -8.897% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -2038.639% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1149.018% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -384.893% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 55.884% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -292.099% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -3915.47% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -18.137% |
| UroGen Pharma Ltd. | -102.24 Million USD | -161.753% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -1101.872% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -150.604% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -4962.39% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -1184.199% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -1004.938% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -155.616% |
| Chimerix, Inc. | -82.09 Million USD | -225.997% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -245.825% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -353.738% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -7006.962% |
| Pluri Inc. | -20.88 Million USD | -1181.248% |
| Cue Biopharma, Inc. | -50.73 Million USD | -427.521% |
| MeiraGTx Holdings plc | -84.02 Million USD | -218.501% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -1773.252% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -3102.396% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -1067.097% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1428.761% |
| CalciMedica, Inc. | -34.35 Million USD | -678.959% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -61.426% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 5.517% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -660.412% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2098.705% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -155.196% |
| Nutriband Inc. | -5.48 Million USD | -4778.973% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -562.115% |
| Vor Biopharma Inc. | -117.86 Million USD | -127.066% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 106.154% |
| ProKidney Corp. | -35.46 Million USD | -654.559% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -123.464% |
| Daré Bioscience, Inc. | -30.16 Million USD | -787.317% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 58.391% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -4705.656% |
| Bicycle Therapeutics plc | -180.66 Million USD | -48.135% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -163.04% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -551.7% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 38.669% |
| Atai Life Sciences N.V. | -40.22 Million USD | -565.342% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -231.837% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -254.374% |
| MediciNova, Inc. | -8.57 Million USD | -3022.283% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -117.094% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -3094.847% |
| GeoVax Labs, Inc. | -25.96 Million USD | -930.652% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -238.961% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -11.866% |
| Biomea Fusion, Inc. | -117.25 Million USD | -128.244% |
| RenovoRx, Inc. | -10.23 Million USD | -2515.588% |
| Erasca, Inc. | -125.04 Million USD | -114.03% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -74.735% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -787.652% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -165.406% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 2000.22% |
| bluebird bio, Inc. | -211.91 Million USD | -26.291% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -38.694% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -990.441% |
| Imunon, Inc. | -19.51 Million USD | -1271.393% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 259.639% |
| BioAtla, Inc. | -123.46 Million USD | -116.769% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 18.223% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -624.315% |
| DBV Technologies S.A. | -72.72 Million USD | -267.994% |
| Fortress Biotech, Inc. | -60.63 Million USD | -341.359% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -26.108% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -162.714% |
| aTyr Pharma, Inc. | -50.38 Million USD | -431.122% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -12.574% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -3207.328% |
| Galecto, Inc. | -38.34 Million USD | -597.872% |
| Akari Therapeutics, Plc | -10 Million USD | -2574.131% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -397415.039% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 195.04% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -51.1% |
| Entera Bio Ltd. | -8.88 Million USD | -2910.766% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -140.242% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -684.807% |
| Xencor, Inc. | -126.08 Million USD | -112.256% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -444.843% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -458.499% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1158.442% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 10766.68% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -3915.47% |
| Portage Biotech Inc. | -75.33 Million USD | -255.23% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -3094.847% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -176.889% |
| OncoCyte Corporation | -27.78 Million USD | -863.345% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -2306.389% |
| Purple Biotech Ltd. | -19.88 Million USD | -1246.212% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -3712.894% |
| Onconetix, Inc. | -37.4 Million USD | -615.395% |
| MacroGenics, Inc. | -9.05 Million USD | -2854.593% |
| Tharimmune, Inc. | -9.31 Million USD | -2771.814% |
| Genprex, Inc. | -30.86 Million USD | -767.216% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -218.66% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -13.437% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -2580.022% |
| Prime Medicine, Inc. | -198.13 Million USD | -35.074% |
| Aditxt, Inc. | -32.38 Million USD | -726.498% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -14918.35% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -4953.366% |
| OKYO Pharma Limited | -16.82 Thousand USD | -1590507.33% |
| Savara Inc. | -54.69 Million USD | -389.281% |
| Curis, Inc. | -47.41 Million USD | -464.459% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -1632.765% |
| Adagene Inc. | -18.94 Million USD | -1312.55% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -797.625% |
| BeiGene, Ltd. | -881.7 Million USD | 69.647% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -10.882% |
| GlycoMimetics, Inc. | -36.89 Million USD | -625.288% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -124.842% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -5252.008% |
| SciSparc Ltd. | -5.12 Million USD | -5125.049% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -5252.008% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -566.452% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -222451.433% |
| Minerva Neurosciences, Inc. | -30 Million USD | -791.931% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -4600.158% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -2.093% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -343.179% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 39.209% |
| ADMA Biologics, Inc. | -28.23 Million USD | -847.721% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -966.625% |
| Clene Inc. | -49.5 Million USD | -440.617% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -89.231% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -39.092% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -441.382% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 18.423% |
| Adicet Bio, Inc. | -142.65 Million USD | -87.6% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1277.936% |
| Absci Corporation | -110.56 Million USD | -142.052% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3560.245% |
| Quantum-Si incorporated | -95.96 Million USD | -178.894% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1735.857% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 302.242% |
| Surrozen, Inc. | -43.04 Million USD | -521.781% |
| Generation Bio Co. | -126.61 Million USD | -111.376% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -267.161% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -162.199% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -224.625% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -359.107% |
| Invivyd, Inc. | -198.64 Million USD | -34.728% |
| Cingulate Inc. | -23.53 Million USD | -1037.147% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 21.74% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -2980.927% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -3370.864% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1273.494% |
| Jaguar Health, Inc. | -41.3 Million USD | -548.007% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -2610.421% |
| 2seventy bio, Inc. | -217.57 Million USD | -23.007% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -723.848% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -196.671% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -336.685% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -1100.792% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -722.382% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -170.9% |
| Kronos Bio, Inc. | -112.67 Million USD | -137.525% |
| Innoviva, Inc. | 179.72 Million USD | 248.912% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -286.761% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -3903.396% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -66.43% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 56.488% |
| Evaxion Biotech A/S | -22.12 Million USD | -1109.614% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -231.484% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -33.768% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -287.113% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -3771.918% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -571.417% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -349.771% |
| Clearmind Medicine Inc. | -11.95 Million USD | -2138.614% |
| AlloVir, Inc. | -190.41 Million USD | -40.547% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -165.775% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 474.775% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -10552058.124% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -211.575% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -74.929% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -616.73% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -24.751% |
| ImmunityBio, Inc. | -583.19 Million USD | 54.11% |
| Korro Bio, Inc. | -81.17 Million USD | -229.704% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -101.993% |
| Kineta, Inc. | -14.09 Million USD | -1798.198% |
| Lantern Pharma Inc. | -15.96 Million USD | -1576.7% |
| BioVie Inc. | -32.12 Million USD | -733.196% |
| Codexis, Inc. | -76.24 Million USD | -251.032% |
| Celularity Inc. | -196.29 Million USD | -36.339% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -563.659% |
| Virax Biolabs Group Limited | -6.73 Million USD | -3874.538% |
| Kodiak Sciences Inc. | -260.49 Million USD | -2.739% |
| Annexon, Inc. | -134.23 Million USD | -99.369% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -337.099% |
| Moderna, Inc. | -4.71 Billion USD | 94.323% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 26.935% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -128.419% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -748.424% |
| Immix Biopharma, Inc. | -15.42 Million USD | -1634.903% |
| Eyenovia, Inc. | -27.26 Million USD | -881.718% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1339.53% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -97.727% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -365.333% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -49923.738% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -250.279% |
| Alkermes plc | 355.75 Million USD | 175.227% |
| Arcellx, Inc. | -70.69 Million USD | -278.592% |
| Moolec Science SA | -51.78 Million USD | -416.765% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -545.802% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -537.602% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -99.996% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -790.991% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -96.848% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -529.8% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -2909.817% |
| Humacyte, Inc. | -110.77 Million USD | -141.593% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -411.021% |
| Geron Corporation | -184.12 Million USD | -45.349% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -299.473% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -2479.04% |
| Royalty Pharma plc | 1.13 Billion USD | 123.583% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1159.822% |
| Notable Labs, Ltd. | -11.26 Million USD | -2275.95% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -55.896% |
| Structure Therapeutics Inc. | -89.62 Million USD | -198.624% |
| IN8bio, Inc. | -30 Million USD | -791.882% |
| 89bio, Inc. | -142.18 Million USD | -88.219% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1280.873% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -178.807% |
| Acasti Pharma Inc. | -12.85 Million USD | -1982.214% |
| Genelux Corporation | -28.29 Million USD | -845.779% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -820.788% |
| Liquidia Corporation | -78.5 Million USD | -240.917% |
| Mustang Bio, Inc. | -51.6 Million USD | -418.637% |
| Immunovant, Inc. | -259.33 Million USD | -3.197% |
| Vericel Corporation | -3.18 Million USD | -8310.654% |
| Quantum-Si incorporated | -95.96 Million USD | -178.894% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -267.372% |
| XOMA Corporation | -40.83 Million USD | -555.451% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -392.278% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -1091.685% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1576.687% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -817.882% |
| Vaxcyte, Inc. | -402.26 Million USD | 33.47% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -46.731% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3560.245% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -2046.167% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -807.487% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -882.55% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -44.915% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -586.434% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -820.693% |
| PepGen Inc. | -78.62 Million USD | -240.38% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -799.012% |
| United Therapeutics Corporation | 984.8 Million USD | 127.176% |
| Solid Biosciences Inc. | -96.01 Million USD | -178.735% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -5485.493% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -49923.738% |
| Immuneering Corporation | -53.47 Million USD | -400.503% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -5160.969% |
| Silo Pharma, Inc. | -3.7 Million USD | -7131.827% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -1947.351% |
| Belite Bio, Inc | -31.63 Million USD | -746.064% |
| Pharming Group N.V. | -10.54 Million USD | -2437.23% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -999.568% |
| Bionomics Limited | -15.49 Billion USD | 98.273% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -262.687% |
| uniQure N.V. | -308.47 Million USD | 13.243% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1218.944% |
| GeoVax Labs, Inc. | -25.96 Million USD | -930.652% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -116.825% |
| Altimmune, Inc. | -88.44 Million USD | -202.585% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -3163.066% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -817.882% |
| Peak Bio, Inc. | -1259.26 USD | -21252619.851% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -920.231% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -1523.458% |
| Benitec Biopharma Inc. | -21.75 Million USD | -1130.412% |
| Zura Bio Limited | -60.36 Million USD | -343.385% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -76.554% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -2133628.889% |
| Compugen Ltd. | -18.75 Million USD | -1327.04% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -6121.689% |
| argenx SE | -295.05 Million USD | 9.295% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -481.179% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -1102.278% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 21.005% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -222.621% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 28.371% |
| PolyPid Ltd. | -23.86 Million USD | -1021.42% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -1601.163% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -1909.815% |
| Forte Biosciences, Inc. | -31.47 Million USD | -750.257% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -514.458% |
| Instil Bio, Inc. | -156.08 Million USD | -71.46% |
| Elevation Oncology, Inc. | -45.7 Million USD | -485.566% |
| Immunome, Inc. | -106.8 Million USD | -150.573% |
| Verona Pharma plc | -54.36 Million USD | -392.242% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -1547616.741% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -167.849% |
| Shattuck Labs, Inc. | -87.29 Million USD | -206.567% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -114.701% |
| Design Therapeutics, Inc. | -66.86 Million USD | -300.268% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -228.724% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -606.475% |
| Achilles Therapeutics plc | -69.66 Million USD | -284.163% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -247.157% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -687.833% |
| MoonLake Immunotherapeutics | -36 Million USD | -643.258% |
| Beam Therapeutics Inc. | -132.52 Million USD | -101.941% |
| Moolec Science SA | -51.78 Million USD | -416.765% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -391.763% |
| AEON Biopharma, Inc. | -52.55 Million USD | -409.223% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -306.944% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -273.864% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 39.729% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -139.882% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -98.07% |
| Athira Pharma, Inc. | -117.67 Million USD | -127.435% |
| HCW Biologics Inc. | -24.99 Million USD | -970.753% |
| XOMA Corporation | -40.83 Million USD | -555.451% |
| NeurAxis, Inc. | -14.62 Million USD | -1729.718% |
| Lumos Pharma, Inc. | -34.03 Million USD | -686.352% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -167.849% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1242.491% |
| Nektar Therapeutics | -276.05 Million USD | 3.053% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -222.621% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 8994.838% |
| Arvinas, Inc. | -367.3 Million USD | 27.137% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -10552058.124% |
| Palisade Bio, Inc. | -12.3 Million USD | -2075.829% |
| Nutriband Inc. | -5.48 Million USD | -4778.973% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -397415.039% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -450.594% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -535.331% |
| Merus N.V. | -154.93 Million USD | -72.731% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -174.692% |
| Neurogene Inc. | -36.31 Million USD | -636.919% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -63.771% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -3048.183% |
| CervoMed Inc. | -2.17 Million USD | -12222.406% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -172.68% |
| Sesen Bio, Inc. | -19.88 Million USD | -1245.941% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -752.723% |
| Rezolute, Inc. | -68.45 Million USD | -290.93% |
| Clene Inc. | -49.5 Million USD | -440.617% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1635.193% |
| BeyondSpring Inc. | -21.02 Million USD | -1172.838% |
| Synlogic, Inc. | -57.28 Million USD | -367.21% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -2148.777% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -2372.076% |
| Peak Bio, Inc. | -1259.26 USD | -21252619.851% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -616.193% |
| Krystal Biotech, Inc. | 10.93 Million USD | 2548.106% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -87.022% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 17.68% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -5694.09% |
| MannKind Corporation | -11.93 Million USD | -2141.808% |
| Ikena Oncology, Inc. | -68.16 Million USD | -292.611% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1173.505% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -187.978% |
| Gossamer Bio, Inc. | -179.81 Million USD | -48.833% |
| CohBar, Inc. | -11.96 Million USD | -2137.288% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -937.797% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -787.652% |
| Legend Biotech Corporation | -518.25 Million USD | 48.36% |
| Mural Oncology plc | -207.44 Million USD | -29.01% |
| Disc Medicine, Inc. | -76.42 Million USD | -250.164% |
| Champions Oncology, Inc. | -7.27 Million USD | -3578.216% |
| REGENXBIO Inc. | -263.49 Million USD | -1.569% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -2421.673% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -463.366% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -604.588% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -167.191% |
| Vaxart, Inc. | -82.46 Million USD | -224.534% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 80284.742% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -612.864% |
| Cellectis S.A. | -101.05 Million USD | -164.823% |
| Longeveron Inc. | -21.41 Million USD | -1149.834% |
| Repare Therapeutics Inc. | -93.79 Million USD | -185.329% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 50.067% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -276.044% |
| Revolution Medicines, Inc. | -436.36 Million USD | 38.669% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -3972.85% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -768.242% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -286.002% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -313.438% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -2627.826% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 107.394% |
| Denali Therapeutics Inc. | -145.22 Million USD | -84.286% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -222451.433% |
| Veru Inc. | -93.15 Million USD | -187.299% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -890.148% |
| Cingulate Inc. | -23.53 Million USD | -1037.147% |
| Passage Bio, Inc. | -102.06 Million USD | -162.22% |
| Context Therapeutics Inc. | -23.96 Million USD | -1016.778% |
| Exicure, Inc. | -16.91 Million USD | -1482.281% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -41.664% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -608.683% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -4012.704% |
| Nuvalent, Inc. | -126.21 Million USD | -112.034% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -2445.034% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -208.046% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -776.202% |
| OmniAb, Inc. | -50.61 Million USD | -428.709% |
| Anew Medical, Inc. | 1.34 Million USD | 19981.289% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -1567.978% |
| Lipocine Inc. | -16.35 Million USD | -1536.654% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -303.089% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -320.302% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -534.281% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -457.94% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1249.539% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 50.576% |
| Ocugen, Inc. | -63.07 Million USD | -324.279% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -179.559% |
| Q32 Bio Inc. | -112.96 Million USD | -136.92% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -1456.695% |
| Alumis Inc. Common Stock | -154.99 Million USD | -72.67% |
| Equillium, Inc. | -13.33 Million USD | -1906.952% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -343.341% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -3250.432% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -1319.68% |
| Dominari Holdings Inc. | -22.88 Million USD | -1069.596% |
| Edesa Biotech, Inc. | -8.37 Million USD | -3095.769% |
| vTv Therapeutics Inc. | -20.25 Million USD | -1221.615% |
| Bio-Techne Corporation | 168.1 Million USD | 259.202% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 23.989% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 307.699% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -119.669% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -605.414% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -137.591% |
| Nkarta, Inc. | -117.5 Million USD | -127.766% |
| BioCardia, Inc. | -11.57 Million USD | -2212.912% |
| Iterum Therapeutics plc | -38.37 Million USD | -597.472% |